COMMUNIQUÉS West-GlobeNewswire
-
Ketogenic Foundation Announces 2026 Conference Exploring the Future of Metabolic Health and Chronic Disease Care
18/08/2026 -
USAHS Celebrates 20,000 Degrees Amid Continued Growth and Program Expansion
18/08/2026 -
Trethera Appoints World-Renowned ALS Researcher Dr. Merit Cudkowicz to Scientific Advisory Board
18/08/2026 -
NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t
18/08/2026 -
Jabra Enhance introduces a new lineup of FDA-cleared self-fitting hearing aids, 3 new models with improved hearing technology and in-app self-tuning
18/08/2026 -
Direct Meds Updates DirectMax Clinical Review and Licensed-Pharmacy Fulfillment Details (2026)
18/08/2026 -
FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
18/08/2026 -
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
18/08/2026 -
Peak Physio Launches Subscription Education Platform Arcane Physio for International Clinician Market
18/08/2026 -
BlossomHill Therapeutics Announces FDA Fast Track Designation for BH-30643, a Macrocyclic OMNI-EGFR™ Inhibitor for the Treatment of Advanced EGFR C797S-positive NSCLC
18/08/2026 -
Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease
18/08/2026 -
Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
18/08/2026 -
ABBYY’s New Executive Appointments Illustrate Focus on Hybrid AI to Drive Enterprise Intelligence
18/08/2026 -
Immatics Announces Second Quarter 2026 Financial Results and Business Update
18/08/2026 -
CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor
18/08/2026 -
General Oncology Nominated for the 2026 Prix Galien USA Best Startup Award
18/08/2026 -
Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
18/08/2026 -
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
18/08/2026 -
BrewDog Unwraps Its 2026 Advent Calendar
18/08/2026
Pages